{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:44:44Z","timestamp":1791139484543,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.jaad.2006.08.017","type":"journal-article","created":{"date-parts":[[2006,10,21]],"date-time":"2006-10-21T07:11:23Z","timestamp":1161414683000},"page":"236-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["High-potency steroid use in children with vitiligo: A retrospective study"],"prefix":"10.1016","volume":"56","author":[{"given":"Jennifer","family":"Kwinter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Khambalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.08.017_bib1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0738-081X(97)00128-4","article-title":"The epidemiology and genetics of vitiligo","volume":"15","author":"Nordlund","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib2","first-page":"239","article-title":"Vitiligo","volume":"60","author":"Schwartz","year":"1997","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.017_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/archderm.1982.01650130009007","article-title":"Vitiligo: it is important","volume":"118","author":"Nordlund","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib4","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archderm.135.12.1514","article-title":"The development of guidelines for the treatment of vitiligo: clinical epidemiology unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology","volume":"135","author":"Njoo","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0738-081X(97)00132-6","article-title":"Non PUVA nonsurgical therapies for vitiligo","volume":"15","author":"Mandel","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0738-081X(03)00045-2","article-title":"The treatment of hypopigmentation in children","volume":"21","author":"Schaffer","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0190-9622(98)70194-X","article-title":"Vitiligo","volume":"38","author":"Kovacs","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.0736-8046.2004.21418.x","article-title":"Calcipotriene and corticosteroid combination therapy for vitiligo","volume":"21","author":"Travis","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib9","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0738-081X(97)00131-4","article-title":"Childhood vitiligo","volume":"15","author":"Halder","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib10","first-page":"474","article-title":"A clinical trial of clobetasol propionate in Filipino vitiligo patients","volume":"9","author":"Geraldez","year":"1987","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2006.08.017_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1346-8138.2001.tb00012.x","article-title":"Vitiligo: a retrospective comparative analysis of treatment modalities in 500 patients","volume":"28","author":"Handa","year":"2001","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archderm.1984.01650410073019","article-title":"Vitiligo treated with topical clobetasol propionate","volume":"120","author":"Kumari","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-4362.2002.01486_3.x","article-title":"Calcipotriol ointment versus clobetasol ointment in localized vitiligo: an open, comparative clinical trial","volume":"41","author":"Kose","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib14","first-page":"88","article-title":"Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo","volume":"15","author":"Coskun","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1046\/j.1365-4362.1998.00557.x","article-title":"Response of segmental vitiligo to 0.05% clobetasol propionate cream","volume":"37","author":"Khalid","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-4362.1995.tb01570.x","article-title":"Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo","volume":"34","author":"Khalid","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/bmj.4.5997.619","article-title":"Effect on adrenal function of topically applied clobetasol propionate (Dermovate)","volume":"4","author":"Allenby","year":"1975","journal-title":"Br Med J"},{"key":"10.1016\/j.jaad.2006.08.017_bib19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0190-9622(96)90691-X","article-title":"Guidelines of care for vitiligo: American Academy of Dermatology","volume":"35","author":"Drake","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3928\/0090-4481-20010401-12","article-title":"The safe use of topical corticosteroids in children","volume":"30","author":"Raimer","year":"2001","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.jaad.2006.08.017_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003263.pub3","article-title":"Interventions for vitiligo","volume":"1","author":"Whitton","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2006.08.017_bib22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/014107688708000709","article-title":"Adrenal suppression following low-dose topical clobetasol propionate","volume":"80","author":"Ohman","year":"1987","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jaad.2006.08.017_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0190-9622(91)70069-E","article-title":"A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis","volume":"24","author":"Olsen","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(79)90597-X","article-title":"Fatal iatrogenic Cushing's syndrome","volume":"1","author":"Nathan","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2006.08.017_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00128071-200203030-00001","article-title":"Topical corticosteroid-induced adrenocortical insufficiency: clinical implications","volume":"3","author":"Levin","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2006.08.017_bib26","first-page":"89","article-title":"Vitiligo in autoimmune thyroid disease","volume":"3","author":"Shong","year":"1991","journal-title":"Thyroidology"},{"key":"10.1016\/j.jaad.2006.08.017_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2249.2003.02089.x","article-title":"Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?","volume":"131","author":"Zettinig","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2006.08.017_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000081479","article-title":"Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo","volume":"210","author":"Iacovelli","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2006.08.017_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1468-3083.2004.00728.x","article-title":"Thyroid function and autoimmunity in children and adolescents with vitiligo","volume":"18","author":"Kurtev","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206022584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206022584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:05:26Z","timestamp":1759269926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962206022584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0190962206022584"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.08.017","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-potency steroid use in children with vitiligo: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}